Publication | Closed Access

New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment

Medicinal ChemistryAlzheimer's DiseaseStructural DevelopmentBiochemistryMedicineNatural SciencesMechanism Of ActionNeuropharmacologyNew InsightsDrug DevelopmentMolecular SubstratePharmacologySelective Pde4d InhibitorsDrug Discovery